Further Kaplan-Meier survival analysis showed that high expression levels of AARS1, especially in combination with high expression of YAP-TEAD1, strongly predicted a poor prognosis for patients with GC in this cohort (Figure 5H). Here, AARS1 is linked to gastric cancer.